Brooks DJ - Search Results

1

Trial of Cinpanemab in Early Parkinson's Disease.

Lang AE, Siderowf AD, Macklin EA, Poewe W, Brooks DJ, Fernandez HH, Rascol O, Giladi N, Stocchi F, Tanner CM, Postuma RB, Simon DK, Tolosa E, Mollenhauer B, Cedarbaum JM, Fraser K, Xiao J, Evans KC, Graham DL, Sapir I, Inra J, Hutchison RM, Yang M, Fox T, Budd Haeberlein S, Dam T; SPARK Investigators. Lang AE, et al. Among authors: brooks dj. N Engl J Med. 2022 Aug 4;387(5):408-420. doi: 10.1056/NEJMoa2203395. N Engl J Med. 2022. PMID: 35921450 Clinical Trial.

2

The Bereitschaftspotential preceding simple foot movement and initiation of gait in Parkinson's disease.

Vidailhet M, Stocchi F, Rothwell JC, Thompson PD, Day BL, Brooks DJ, Marsden CD. Vidailhet M, et al. Among authors: brooks dj. Neurology. 1993 Sep;43(9):1784-8. doi: 10.1212/wnl.43.9.1784. Neurology. 1993. PMID: 8414032

3

Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group.

Rascol O, Brooks DJ, Brunt ER, Korczyn AD, Poewe WH, Stocchi F. Rascol O, et al. Among authors: brooks dj. Mov Disord. 1998 Jan;13(1):39-45. doi: 10.1002/mds.870130111. Mov Disord. 1998. PMID: 9452324 Clinical Trial.

4

Ropinirole versus bromocriptine in the treatment of early Parkinson's disease: a 6-month interim report of a 3-year study. 053 Study Group.

Korczyn AD, Brooks DJ, Brunt ER, Poewe WH, Rascol O, Stocchi F. Korczyn AD, et al. Among authors: brooks dj. Mov Disord. 1998 Jan;13(1):46-51. doi: 10.1002/mds.870130112. Mov Disord. 1998. PMID: 9452325 Clinical Trial.

5

A placebo-controlled evaluation of ropinirole, a novel D2 agonist, as sole dopaminergic therapy in Parkinson's disease.

Brooks DJ, Abbott RJ, Lees AJ, Martignoni E, Philcox DV, Rascol O, Roos RA, Sagar HJ. Brooks DJ, et al. Clin Neuropharmacol. 1998 Mar-Apr;21(2):101-7. Clin Neuropharmacol. 1998. PMID: 9579296 Clinical Trial.

6

The safety of ropinirole, a selective nonergoline dopamine agonist, in patients with Parkinson's disease.

Schrag AE, Brooks DJ, Brunt E, Fuell D, Korczyn A, Poewe W, Quinn NP, Rascol O, Stocchi F. Schrag AE, et al. Among authors: brooks dj. Clin Neuropharmacol. 1998 May-Jun;21(3):169-75. Clin Neuropharmacol. 1998. PMID: 9617508 Clinical Trial.

7

Guidelines for the management of Parkinson's disease. The Parkinson's Disease Consensus Working Group.

Bhatia K, Brooks DJ, Burn DJ, Clarke CE, Playfer J, Sawle GV, Schapira AH, Stewart D, Williams AC. Bhatia K, et al. Among authors: brooks dj. Hosp Med. 1998 Jun;59(6):469-80. Hosp Med. 1998. PMID: 9775275

8

Atypical parkinsonism in Afro-Caribbean and Indian origin immigrants to the UK.

Chaudhuri KR, Hu MT, Brooks DJ. Chaudhuri KR, et al. Among authors: brooks dj. Mov Disord. 2000 Jan;15(1):18-23. doi: 10.1002/1531-8257(200001)15:1<18::aid-mds1005>3.0.co;2-z. Mov Disord. 2000. PMID: 10634237 Review.

9

Late onset levodopa responsive Huntington's disease with minimal chorea masquerading as Parkinson plus syndrome.

Reuter I, Hu MT, Andrews TC, Brooks DJ, Clough C, Chaudhuri KR. Reuter I, et al. Among authors: brooks dj. J Neurol Neurosurg Psychiatry. 2000 Feb;68(2):238-41. doi: 10.1136/jnnp.68.2.238. J Neurol Neurosurg Psychiatry. 2000. PMID: 10644798 Free PMC article.

10

The catechol-O-methyltransferase (COMT) inhibitor entacapone enhances the pharmacokinetic and clinical response to Sinemet CR in Parkinson's disease.

Piccini P, Brooks DJ, Korpela K, Pavese N, Karlsson M, Gordin A. Piccini P, et al. Among authors: brooks dj. J Neurol Neurosurg Psychiatry. 2000 May;68(5):589-94. doi: 10.1136/jnnp.68.5.589. J Neurol Neurosurg Psychiatry. 2000. PMID: 10766888 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

726 results

Search Page

Filters